24 May 2013
Keywords: eusa, pharma, enters, 30m, financing, round, usa-based
Article | 17 December 2007
USA-based speciality drugmaker EUSA Pharma has entered into a $30.0 million debt facility offered by Merrill Lynch Capital, a division of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.